The potential of GmA as a therapeutic compound for skeletal muscle atrophy was compared with compound Gi8, which was previously derived from G. inodorum and shown to possess insulin mimetic activity [4], and compound Gi1, which is a diglycoside form of GmA (Figure S3). The gene discussed is INS; the disease is Skeletal muscle atrophy.